Gentex Analyst Price Targets - Benzinga

Gentex Corp

GNTXNASDAQ

Trade with Public

Trade with Public

$21.20

0.412%

最終更新: Oct 15, 1:31 PM

$21.05

0.271.3%

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Gentex Analyst Price Targets - Benzinga

Gentex Analyst Price Targets

Wall Street analyst price targets and consensus rating for Gentex (GNTX).

Price Target Range — 12 Quarters

Analyst Consensus — 7 Analysts

2Buy

4Hold

1Sell

Consensus RatingNeutral# Analysts7Avg. Consensus PT$27Upside to Avg. PT+25.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	UBS	Joseph Spak	PT Cut	Neutral	$25→$24
Oct 6, 2026	Goldman Sachs	Mark Delaney	Downgrade	Neutral→Sell	$23→$20
Aug 10, 2026	JP Morgan	Rajat Gupta	PT Cut	Neutral	$28→$27
Jul 9, 2026	UBS	Joseph Spak	PT Cut	Neutral	$26→$25
May 14, 2026	JP Morgan	Rajat Gupta	PT Raise	Neutral	$27→$28
Apr 27, 2026	Baird	David Leiker	PT Raise	Neutral	$25→$26
Apr 27, 2026	B. Riley Securities	Josh Nichols	PT Raise	Buy	$28→$29
Apr 23, 2026	JP Morgan	Ryan Brinkman	PT Cut	Neutral	$28→$27
Apr 14, 2026	UBS	Joseph Spak	PT Cut	Neutral	$25→$24
Feb 2, 2026	B. Riley Securities	Josh Nichols	PT Cut	Buy	$32→$28
Oct 27, 2025	Goldman Sachs	Mark Delaney	PT Cut	Neutral	$30→$27
Oct 20, 2025	JP Morgan	Ryan Brinkman	PT Raise	Neutral	$30→$32
Oct 6, 2025	UBS	Joseph Spak	PT Raise	Neutral	$28→$29
Jul 28, 2025	UBS	Joseph Spak	PT Raise	Neutral	$23→$28
Jul 28, 2025	B. Riley Securities	Josh Nichols	PT Raise	Buy	$28→$32
Jul 28, 2025	Baird	David Leiker	PT Raise	Neutral	$26→$30
Jul 14, 2025	UBS	Joseph Spak	PT Raise	Neutral	$21→$23
Jul 11, 2025	Baird	David Leiker	PT Raise	Neutral	$25→$26
Apr 22, 2025	Guggenheim	Ronald Jewsikow	PT Cut	Buy	$30→$24
Apr 15, 2025	Baird	David Leiker	Downgrade	Outperform→Neutral	$31→$25

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Gentex, Lowers Price Target to $24

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $25 to $24.

Benzinga Newsdesk

This Gentex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.

Avi Kapoor

PRO
Goldman Sachs Downgrades Gentex to Sell, Lowers Price Target to $20

Goldman Sachs analyst Mark Delaney downgrades Gentex (NASDAQ:GNTX) from Neutral to Sell and lowers the price target from $23 to $20.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $27

JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Gentex, Lowers Price Target to $25

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Gentex, Raises Price Target to $28

JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $27 to $28.

Benzinga Newsdesk